Implementation of Digital Consent at Sandwell and West Birmingham NHS Trust: A Quality Improvement Project Authors: Maiar Elhariry, Chaninda Dejsupa, Amirul Adlan, Joanna Richards, Martin Li, Gary Weekes, Tahir Khaleeq, Kanthan Theivendran Published: 2025 ABSTRACT AbstractDigital consent systems provide a modern alternative to traditional paper-based methods, improving legibility, documentation accuracy, compliance with National Health Service (NHS) medicolegal standards and patient understanding. This quality improvement project evaluated the implementation of a digital consent system in the Trauma and Orthopaedics department at Sandwell and West Birmingham NHS Trust, comparing paper-based consent with the digital system. Baseline data were collected retrospectively from July to August 2024 and compared with prospective data following implementation from August to October 2024, using quantitative measures of documentation quality and qualitative feedback from healthcare professionals (n=24) and patient (n=619) surveys. An iterative Plan-Do-Study-Act cycle approach was used to refine the process.Following implementation, legibility improved from 42–48% to 100% across all digital consents, and documentation of alternative treatment options increased substantially from 5% to 95% in trauma cases and from 0% to 98% in elective cases. Risks and benefits were documented in 100% of digital consents. Patient and clinician surveys demonstrated high satisfaction, with a mean System Usability Score of 77.5, comparable to high-performing consumer technology platforms. Identified barriers included accessibility issues for less digitally literate patients and technical challenges such as digital signing on smaller devices. The transition to digital consent resulted in a cumulative cost saving of £2552.90 over the first 7 months.The introduction of digital consent significantly improved documentation quality, patient and clinician satisfaction and generated measurable cost savings. Ongoing challenges relating to accessibility and technical usability require targeted interventions. This project demonstrates the potential for digital consent systems to support efficient, sustainable and patient-centred care, with opportunities for broader adoption across NHS specialties. WHAT IS ALREADY KNOWN ON THIS TOPIC Paper-based consent is often illegible and inconsistently records key information, exposing patients and clinicians to risk and undermining trust in shared decision-making. Paper-based consent is often illegible and inconsistently records key information, exposing patients and clinicians to risk and undermining trust in shared decision-making. WHAT THIS STUDY ADDS Introducing digital consent in Trauma and Orthopaedics achieved 100% legibility, raised documentation of alternative treatment options from 5% to over 95%, improved patient and clinician experience and saved £2552.90 within 7 months. Introducing digital consent in Trauma and Orthopaedics achieved 100% legibility, raised documentation of alternative treatment options from 5% to over 95%, improved patient and clinician experience and saved £2552.90 within 7 months. HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY These findings provide strong evidence for scaling digital consent across the National Health Service to deliver safer, more consistent and patient-centred consent processes. They also highlight the potential of digital systems to transform documentation quality, improve medicolegal compliance and support equitable shared decision-making. These findings provide strong evidence for scaling digital consent across the National Health Service to deliver safer, more consistent and patient-centred consent processes. They also highlight the potential of digital systems to transform documentation quality, improve medicolegal compliance and support equitable shared decision-making. Background Informed consent is a fundamental ethical and legal requirement in medical practice, ensuring patients understand the risks, benefits and alternatives before giving consent to a procedure. The General Medical Council outlines that consent must be voluntary, informed and documented appropriately to uphold patient autonomy and trust in healthcare professionals (HCPs).1 In Trauma and Orthopaedics (T&O), where surgical interventions range from elective joint replacements to emergency trauma procedures, high-quality consent documentation is crucial. Poorly documented consent risks medicolegal challenges, patient dissatisfaction and potential breaches of ethical standards.2 Studies have highlighted that paper consent forms frequently suffer from illegibility, incomplete documentation and inconsistencies in recording key elements such as risks, alternative treatments and patient understanding.3 These shortcomings impact patient satisfaction and trust, leaving patients uninformed and potentially heightening anxiety about their procedures.4 In trauma cases where different clinicians may be involved in consent and surgery at different sites, paper forms may be inaccessible or unclear from poor legibility, creating uncertainty about what was discussed with the patient.5 Furthermore, incomplete or missing documentation poses legal risks, as failure to meet national consent standards places both hospitals and responsible clinicians at risk.6 Paper-based documentation also carries financial and environmental burdens. Besides incurring additional costs to the National Health Service (NHS), time is spent scanning and uploading consent forms into patients’ electronic patient records (EPR), contributing to inefficiencies.7 8 Moreover, storage generates further waste and negative environmental impact. Digital consent systems offer a solution aligned with the NHS strategy for sustainability and cost-effectiveness.8 Evidence shows digital consent enhances documentation quality, improves patient understanding and streamlines surgical workflows.9 Digital consent ensures clear, legible and complete documentation that reduces omissions while aligning with NHS and legal standards.10 11 Additionally, digital consent reduces administrative burden, allowing clinicians to focus more on patient care rather than paperwork.12 Real-time tracking and audit functions support accountability and traceability, especially valuable in T&O where multiple teams may be involved in patient care.13 From an environmental perspective, digital consent reduces paper waste and storage needs, contributing to NHS sustainability goals.14 Several NHS Trusts have piloted digital consent with promising results.1517 However, implementation remains variable, and comparative data between digital and paper consent are limited, particularly regarding patient and HCP perspectives. To our knowledge, this project is the first to take a holistic approach to assessing digital consent efficacy, considering medicolegal compliance, environmental sustainability, efficiency and user experience in both routine and emergency procedures. We aim to evaluate the impact of digital consent implementation within the T&O department at Sandwell and West Birmingham NHS Trust on documentation quality, patient and clinician satisfaction and cost efficiency. Given the high patient turnover and diverse case complexity in T&O, our findings have the potential to guide broader NHS adoption of digital consent, ensuring better patient experience, more efficient clinical workflows and improved documentation standards. Methods Measurement We began with a retrospective evaluation of both trauma and elective cases using paper consent forms before the introduction of digital consent. This allowed us to establish baseline data regarding key factors such as legibility, completeness, timeliness and NHS compliance. Legibility was assessed independently by two assessors. Digital consent was introduced on 11 August 2024. To evaluate the implementation and effectiveness of the digital consent system, we conducted a repeat service evaluation 3 months after the implementation (November 2024), using a similar case number. This allowed comparison of paper and digital consents across trauma and elective cases. We then conducted a third Plan-Do-Study-Act (PDSA) cycle to assess the utilisation, sustainability and feasibility. We used surveys to collect qualitative data from HCPs and patients after implementation. The HCP survey explored user satisfaction, ease of use, barriers to implementation and suggestions for improvement. The patient survey assessed user experience, impact on communication with clinicians and identified areas for improvement in the digital consent process. Quantitative data were extracted from patient records, focusing on legibility, completeness, accuracy, timeliness and NHS compliance. Qualitative data were gathered from the surveys and analysed descriptively, informed by the international standard System Usability Score (SUS).18 Variables analysed in each cycle included: legibility (yes/no), documentation of risks (yes/no), benefits (yes/no), alternative treatment options discussed (yes/no), signature and grade of consenting clinician (consultant or registrar) and type of consent form (consent 1 is an informed consent where the patient has capacity, consent 2 is for paediatric patients, consent 3 is for patients whose consciousness is not impaired during surgery and consent 4 is for patients who lack the capacity to consent). Baseline retrospective data were collected from paper consent forms (July–August 2024). Prospective data were collected from the digital consent platform (August–October 2024) from operating theatre lists. Data were extracted by two independent assessors to reduce bias. HCP feedback was collected via anonymised Google Forms survey distributed to internal Trust mailing lists. Patient feedback was gathered either via secure SMS link postprocedure or a ward-based tablet survey prior to discharge. Participation was voluntary and anonymous; completion implied consent. Patient signatures were captured electronically using a stylus, finger or mouse following a unique QR code. For patients unable to sign, clinicians documented verbal confirmation of consent in electronic records in line with Trust policy. To reduce confounding, we controlled for staff turnover (none during the study) minimising variability in individual clinical practice, maintained similar case numbers preintervention and postintervention and conducted evaluation within the same hospital setting and workflow. Data collection methods were standardised with two independent assessors evaluating consent forms for legibility and completeness to reduce bias, and the study covered comparable timeframes to avoid seasonal bias. Design This project was registered with the Sandwell and West Birmingham NHS Trust Clinical Effectiveness Department as a quality improvement initiative (reference number: 2814). According to the hospital’s local guidance, formal research ethics approval was not required, as the project focused on improving existing care processes and did not involve randomisation or novel interventions. The primary intervention was the introduction of a digital consent system, replacing traditional paper-based consent forms. The Trust underwent a comprehensive procurement exercise to choose a digital consent supplier, and Concentric Health was chosen to standardise documentation, improve legibility and compliance, support patient engagement and streamline workflows. Ethical approval to conduct this project was not acquired as per Medical Research Council Ethics Tool. Recognising that successful implementation requires adaptability, refinement was achieved through a second PDSA cycle based on patient and HCP feedback. To facilitate smooth implementation, we engaged with key stakeholders across the multidisciplinary team, including foundation doctors, core surgical trainees, T&O specialty registrars and consultants, who all play key roles in consent. For example, it is a common practice for registrars and consultants to complete and cosign consent forms, while resident doctors (foundation and surgical resident doctors) address patient queries. This ensured diverse perspectives and early awareness. Moreover, it ensured the team was informed about the upcoming change, formally via emails and informally via these discussions, and asked to relay information to their respective teams. Additionally, we conducted brief educational sessions to introduce the digital consent system, ensuring that all users were familiar with its functionality and benefits. At the planning stage, we anticipated several challenges. User resistance was a key concern, as clinicians accustomed to paper-based consent might initially be hesitant to adopt a new digital system. To address this, we provided brief training sessions and ongoing support to ease the transition. Technical issues, such as software compatibility or system downtime, were also considered, and we liaised with the hospital’s information technology department to ensure adequate technical support. Additionally, we recognised that variability in patient digital literacy could be a barrier, so we ensured that clinicians could still explain consent information verbally and provide supplementary written materials if needed. (The digital consent solution has the ability to print out the consent form.) To ensure the long-term success of digital consent, we incorporated strategies for sustainability and continued engagement by integrating the system into routine clinical practice and existing workflows. The digital consent platform was integrated into our EPR system adhering to the Health Level 7 (HL7) standards, which are international standards of sharing healthcare data, ensuring PDF versions were accessible to all staff. Regular audit cycles and ongoing feedback mechanisms were planned for future refinements. Finally, we advocated for hospital-wide adoption, emphasising the benefits of digital consent in improving patient safety, documentation accuracy and overall efficiency. Strategy PDSA cycle 1: baseline service evaluation of paper-based consent (July–August 2024) The first cycle aimed to establish a baseline for the quality of consent documentation using the existing paper-based system. Our change hypothesis was that the current process lacked consistency and structure, resulting in variable documentation standards. The strategy was to assess the quality of consent documentation by conducting a retrospective audit of 40 paper consent forms in both trauma and elective patients (before 11 August 2024). Baseline data collected included legibility, completeness, documentation of risks and benefits, alternative options and the grade of the consenting clinician. As predicted, the findings revealed a significant lack of effective documentation, particularly in legibility and the lack of discussion of alternative options. This confirmed our hypothesis and provided a clear rationale for implementing a digital consenting system; thus, these insights directly informed the change process in cycle 2 by identifying the need for a structured and standardised consent tool. PDSA cycle 2: introducing digital consent (August–October 2024) The second cycle aimed to evaluate the effectiveness of implementing a digital consent system in addressing the pitfalls identified in cycle 1. We hypothesised that the digital system would improve documentation legibility, facilitate completeness of recording key consent elements, increase compliance with NHS standards and improve patient understanding. The strategy was to conduct a prospective audit of 40 consecutive electronic consent forms using the same criteria as cycle 1 (after 11 August 2024). Implementation involved rolling out the digital consent system trust-wide, supported by basic user guidance. Results showed substantial improvements in legibility and completeness, with more consistent documentation of benefits, risks, alternative options and clinician grade. These outcomes aligned well with our predictions, suggesting the intervention was effective. However, some variability remained largely due to differences in staff and patient familiarity with the system. The key learning was that while digital consent offers advantages, its success depends on user-friendly navigation and understanding. This highlighted the need for more comprehensive training, which was the focus of cycle 3. PDSA cycle 3: encouraging the implementation, refinement and sustainability of digital consent (February–March 2025) PDSA cycle 3 (February–March 2025) focused on refining the digital consent process based on feedback collected during cycle 2. Data collection involved reviewing 80 patient consent forms (40 trauma cases and 40 elective cases). Elective cases included a mix of paper and digital forms, as some patients were already consented on paper prior to the digital rollout. These were analysed separately to avoid bias. Additionally, feedback questionnaires were distributed to both clinicians and patients. Clinicians were invited via email, while patients received surveys either on discharge (via tablet) or through a secure SMS link. Data collected included satisfaction, usability, perceived barriers and suggestions for improvement. Key refinements made after cycle 3 included: increased staff training, technical support improvements, creation of printed backup forms and recommendations for translated patient materials and larger signing devices. Results Baseline results (cycle 1: paper consent) At baseline, a total of 79 patient consent forms were reviewed, comprising 39 trauma cases and 40 elective cases. The paper-based consent process demonstrated several deficiencies. Among trauma cases, legibility was poor, with only 42% (n=16/39) of forms deemed legible. Documentation of risks and benefits was present in 91% (n=35/39) of cases, while alternative treatment options were rarely recorded, appearing in just 5% (n=2/39). The majority of these consents were completed by registrars (85%, n=33/39), with consultants completing the remaining 15% (n=6/39). In elective cases, legibility was similarly low at 48% (n=19/40). Documentation of risks and benefits was identified in 45% (n=18/40), and no alternative treatment options were recorded (0%). In this group, a higher proportion of consents were completed by consultants (62.5%, n=25/40) compared with registrars (37.5%, n=15/40). Across both trauma and elective groups, consent form type 1 was the most commonly used, with little variation (see the Measurement section). These baseline findings highlighted clear gaps in legibility, completeness and standardisation, forming the basis for implementing a digital consent system. Post implementation results (cycle 2: digital consent) Following the introduction of the digital consent system, 80 patient consent forms were reviewed, comprising 40 trauma and 40 elective cases. Among trauma patients, legibility improved dramatically, increasing from 42% at baseline (cycle 1) to 100% (n=40/40). Documentation of risks and benefits also improved, rising from 91% to 100% (n=40/40). The most striking improvement was seen in the documentation of alternative treatment options, which increased from 5% at baseline to 95% (n=38/40). There was also a shift in the grade of the consenting clinician, with consultants decreasing from 15% at baseline to 3% (n=1/40) and registrars increasing from 85% to 98% (n=39/40). The distribution of consent types remained similar, with consent form type 1 accounting for 68% (n=27/40), consent form type 2 for 18% (n=7/40) and consent form type 4 for 13% (n=6/40). In elective patients, similar improvements were observed. Legibility increased from 48% to 100% (n=40/40). Documentation of risks and benefits rose from 45% to 100% (n=40/40), while alternative treatment options increased from 0% to 98% (n=39/40). There was also a rise in registrar involvement in the consenting process, increasing from 37.5% to 75%. All elective consents used consent form type 1 both before and after implementation. These findings demonstrate significant improvements in documentation accuracy and completeness following the transition to digital consent. Cycle 3: refinement data During cycle 3 (February–March 2025), 80 elective patient cases were reviewed to evaluate the sustained impact of digital consent and to refine the process based on user feedback from cycle 2. These included a mix of digital and paper consents, with 69 cases completed digitally and 11 completed on paper. Paper consents were only used for patients who had been consented prior to the implementation date and were already on the waiting list, to avoid the need for reconsenting. Among trauma patients, all cases were completed digitally. Legibility, documentation of risks and benefits and documentation of alternative treatment options were each maintained at 100%, demonstrating sustained improvement. All trauma consents were completed by registrars (100%). In elective patients, clear differences were observed between paper and digital consents. Legibility for paper consents was 87% (n=10/11), compared with 100% (n=69/69) for digital consents. Documentation of risks and benefits was 100% in both groups. However, alternative treatment options were not recorded at all in paper consents (0%, n=0/11), while all digital consents included this information (100%, n=69/69). The grade of the consenting clinician also differed: in the paper group, 63% (n=7/11) of consents were completed by consultants and 37% (n=4/11) by registrars, whereas in the digital group, 91% (n=63/69) were completed by registrars and only 9% (n=6/69) by consultants. Regarding consent types, all paper consents were consent type 1, whereas digital consents were primarily consent type 1 (91%, n=63/69) with a small proportion using consent type 3 (9%, n=6/69). These findings demonstrate that digital consent maintained the improvements seen in earlier cycles and outperformed legacy paper processes, particularly in documenting alternative treatment options and improving legibility (figure 1). Change in documentation of different parameters (legibility, alternatives, benefits and risks) in consent over the three Plan-Do-Study-Act (PDSA) cycles. Survey feedback Healthcare professionals HCP surveys were completed by 13 participants during cycle 2 and 11 during cycle 3, comprising doctors, nurses and allied health professionals. Across both cycles, respondents reported high levels of satisfaction with the digital consent platform, particularly regarding ease of use, layout and integration into existing workflows. There was a strong likelihood expressed to continue using the system and to recommend it to colleagues. However, areas for improvement were identified. In cycle 2, both groups reported a need for better technical support, with mixed ratings regarding onboarding and troubleshooting. By cycle 3, these concerns persisted, with additional feedback highlighting the need for structured onboarding of new staff and improved access to training resources. There were also concerns about system reliability, particularly within theatre settings, where clinicians expressed a strong preference for having printed backup copies available. Nevertheless, clinicians also appreciated having the consent forms accessible from the EPR, with less risk of having to look for missing paper consent forms from patients’ physical folders. Collectively, these findings suggested that while the system was intuitive and user-friendly, further refinements were needed to support smooth implementation at scale. Patients Patient surveys were completed by 353 respondents during cycle 2 and 266 during cycle 3. Across both cycles, patients provided highly positive feedback (table 1). They highlighted improved efficiency, clarity, professionalism and convenience compared with the paper consent process. Table 1Patient survey themes from surveys disseminated in PDSA cycles 2 and 3Patient feedback theme frequency Cycle 2: August–November 2024 (n=353) Theme Count Percentage Efficiency10228.9Clarity7822.1Accessibility/technical barriers6418.1Professionalism5716.1Technical issues329.1Consent validity concerns195.4Signing issues10.3 Cycle 3: January–April 2025 (n=266) Theme Count Percentage Technical issues15658.6Accessibility/technical barriers7327.4Efficiency4918.4Clarity3814.3Consent validity concerns197.1Professionalism155.6Signing issues31.1PDSA, Plan-Do-Study-Act. Patient survey themes from surveys disseminated in PDSA cycles 2 and 3 PDSA, Plan-Do-Study-Act. A small proportion of patients reported challenges, primarily related to navigation and usability, particularly among those less familiar with digital technology. In cycle 3, a minor issue was identified regarding difficulties signing consent forms on smaller screens or when using fingers rather than a stylus. However, this was rare, with only 1.1% of patients in cycle 2 and 0.3% in cycle 3 reporting this problem. The vast majority of patients experienced no issues signing digitally, particularly when using smartphones or desktop devices. Suggested improvements included providing stylus pens or dedicated digital signing pads to enhance the signing experience. System usability and cost savings The mean SUS for the digital consent platform was 77.5, which is comparable to high-performing consumer technology platforms developed by companies such as Apple and Google (figure 2). This reflects strong overall usability and a high likelihood of continued adoption by users. The System Usability Score (SUS) for the digital consent platform, as per user feedback. The transition to digital consent also generated clear economic benefits. Each paper consent form previously cost £0.98 to print. During cycle 2 (August–November 2024), there were 1444 digital consent episodes, resulting in cost savings of £1415.12. During cycle 3 (January–March 2025), a further 1161 episodes generated additional savings of £1137.78. This equates to a total saving of £2552.90 within the first 7 months of implementation.19 Summary of improvements The implementation of digital consent resulted in substantial and sustained improvements across all domains assessed. Legibility reached 100% for all digital consents, compared with just 42–48% at baseline. Documentation of alternative treatment options showed a dramatic increase, improving from 5% to 95% in trauma cases and from 0% to 98% in elective cases. The system also reduced reliance on consultants for the consent process, empowering registrars to take a more active role. Both patients and clinicians reported high levels of satisfaction with the digital consent process, with feedback highlighting improved clarity and efficiency. Additionally, the system generated significant cost savings, exceeding £2500 in the first 7 months. These findings demonstrate that digital consent is both clinically effective and economically sustainable, supporting its continued expansion across the Trust and potential replication in other settings. Discussion The project aim was to evaluate the impact of digital consent on documentation quality, patient and clinical satisfaction and cost efficiency, with a focus on enhancing these benefits through clinician and patient feedback and system usability. During data collection, there were notable findings regarding paper consent, including missing consent forms or inaccessible consent forms scanned into the EPR, leading to the exclusion of some patients from our data. Furthermore, there were significant communication gaps, particularly in the documentation of discussions with next of kin and alternative treatment options. Documentation is of utmost importance, especially in the surgical setting; the absence of recorded discussions is interpreted as these conversations not occurring during data collection, underscoring the need for clearer documentation practices to ensure comprehensive and transparent informed consent. The key strengths of this project include significant improvement in all assessed aspects of documentation, including legibility, discussion of risks and benefits and discussion of alternative options following implementation of digital consent. Furthermore, there was increased cost efficiency from the transition from paper-based to digital consent. Qualitative feedback from HCPs and patients was encouraging; indeed, patients appreciated being more integrated in the consent process, but barriers such as clinician adaptation and patient usability issues required iterative refinements. A limitation was the variability in digital literacy among patients, impacting independent navigation. These challenges were addressed through targeted training and supplementary verbal explanations. It is important to note that data collection in cycle 3 was a mixture of paper and digital consents for mostly elective patients; this is because digital consent was introduced after patients on the elective list were consented. We did not reconsent them electronically due to the administrative workflow, which would have meant a longer wait for their procedure. The generalisability of these findings is unlikely to be limited to this specific trust since the consent process is relatively standardised across the country under national ethicolegal guidelines. However, there may be limited generalisability across specialties since this project collected data from T&O patient records. Furthermore, the success of digital consent is almost entirely dependent on internet access and is currently only available in one language (ie, English). Bias was minimised through structured surveys filled out by HCPs and patients not involved in the project, though confounding factors such as varying patient demographics and culture may have influenced outcomes. Future iterations should incorporate hybrid consent options, different language options, offline availability, ongoing user feedback and implementation in other specialties for continuous improvement. Furthermore, with the advent of artificial intelligence (AI) and large language models (LLM), the potential to automate the process of providing consent in different languages could be made possible without burdening the healthcare system and users. However, any AI functionality will require regulatory approval and quality checking to avoid errors as a result of hallucinations and omissions.20 Digital consent is a critical part of the shared decision-making (SDM) process for patients undergoing procedures in which the consent forms an important part of that process.21 To enhance understanding and patient engagement in SDM consent detailing benefits, risks and alternative treatment options ideally must be replicated in a language that is understandable by the patient within a clinical letter to the patient, particularly in an elective setting. This could be enhanced by retrieval augmented generation (RAG) using the curated completed digital consent form as an input for the LLM to create a letter to the patient as part of the clinical letter, providing multiple points of information available to the patient. RAG has been shown to reduce the hallucination rates and potentially make it suitable for clinical settings.22 This will close the SDM loop, providing comprehensive documentation and patient information with reduced administrative and clinical workload. Conclusion In summary, the implementation of digital consent has significantly improved documentation of consent and its efficiency, directly achieving our baseline aims. Our results support existing literature on the positive impact of digital consent and further add a holistic approach by incorporating qualitative data on patients and HCPs, cost efficiency (saving £0.98 per paper form) and stratifying efficiency in routine and emergency procedures. The digital consent system is now well established at our trust within T&O and is sustainable as it seamlessly integrates with our existing EPR system. It has proved to be scalable, with at least 3350 episodes of digital consent since its implementation in August 2024 until May 2025. The focus is on long-term success, including expansion into other specialties and ongoing refinements based on qualitative feedback. Thus, future steps include refining digital accessibility, expanding implementation and conducting further studies on patient engagement and the possibility of exploring how AI and LLM can further enhance SDM without burdening healthcare workers.